November 20, 2026

FDI can boost drug industry: BAPI

Drug exports can go up susbtantially if the country's pharmaceutical sector is allowed to invest overseas, according to the Bangladesh Association of Pharmaceuticals Industry (BAPI).

bdnews24.com News Service

bdnews24.com

Published : 11 Dec 2010, 01:50 PM

Updated : 24 Apr 2022, 05:50 PM

Dhaka, Dec 11 (bdnews24.com)—Drug exports can go up susbtantially if the country's pharmaceutical sector is allowed to invest overseas, according to the Bangladesh Association of Pharmaceuticals Industry (BAPI). By investing in foreign countries the local companies will be able to start joint ventures, make acquisitions and even set up own subsidiary, allowing instant penetration in overseas markets, a BAPI-organised seminar was told. "The country's pharmaceutical industry has the potential to be one of the largest export sectors of Bangladesh, if the barriers are removed", BAPI adviser Nazmul Hasan said in his welcome address at the seminar on Saturday titled 'Pharma Vision 2015'. According to him, the drug producers of the country are facing problems regarding product registration and promotion in foreign markets. "We are probably the only industry in this country, which is facing obstacles to export," said Hasan, the top official of Beximco Pharmaceuticals. In the $808 billion global pharmaceutical market in 2009, Bangladesh could grab a slice of only $47 million. However, the finance minister, who attended the seminar as the chief guest, was reluctant about the idea of allowing local investment abroad. "In the context of our foreign transactions, capital export cannot be allowed," said AMA Muhith. The restrictions, however, can be relaxed in specific cases, he added. The seminar also stressed on the greater need for upgrading the drug regulatory body and the national control laboratory to international standards. "The Directorate General of Drug Administration and the national control laboratory need to become WHO approved as well as the PIC/S," BAPI general secretary Abdul Muktadir said in a presentation on the overall scenario of the industry. According to him, membership of the Pharmaceutical Inspection Cooperation Scheme, or PIC/S, allows entry to member country markets without registration of products. "There are 370 approved positions in the DGDA, of which 240 are vacant." The BAPI official also stressed the issue of allowing investing abroad. BAPI president Salman F Rahman supported his position. "In the 1980s, major policy changes boosted the RMG industry by allowing back-to-back LC and bonded warehouse facilities, the time has now come for another bold decision for the pharma industry," said the vice-chairman of Beximco Group. According to him, Bangladesh has a tremendous potential to be a major producer of generic drugs. Currently, China and India are the major global suppliers for generic items. "Now-a-days, China also has started to import generic drugs due to their growth, which leaves only India as our competitor," said Rahman. Moreover, the developed countries are now showing interest to import generic drugs as medical cost has gone up in those countries, he added. Citing the Indian example, Rahman said that the country had allowed pharmaceutical companies to invest abroad at a time when its foreign reserve was very low. Responding to the concerns of the industry, the finance minister made it very clear that at this moment he was not willing to allow "capital export". However, he said that he hoped that the issue could be resolved by discussion between the government and the industry. Muhith emphasised on the issue of sub-standard drugs produced in the country. "Quality control is crucial for drugs. Apart from a few companies, quality of drugs produced in the country is questionable." He came up with the idea of mandatory membership of BAPI for all licensed drug producers. "This way, the association can also contribute to quality control of the whole industry." The finance minister assured of reorganising and strengthening the drug regulatory body. The seminar also heard from prime minister's advisers Mashiur Rahman and Syed Modasser Ali, health minister A F M Ruhal Haque and industries minister Dilip Barua. bdnews24.com/rhn/am/1930h
Related Stories